Skip to content

Candel Therapeutics, Inc. CADL Balance Sheet Statement

TTM Q1 '26TTM Q4 '25TTM Q3 '25TTM Q2 '25TTM Q1 '25
$194.83M+111%$119.73M+16.6%$86.96M+425%$100.69M+369%$92.17M+258%
$197.75M+112%$121.39M+16.9%$90.13M+398%$103.61M+356%$93.15M+243%
$2.08M+5.6%$1.64M-25.1%$1.36M-45.0%$1.66M-39.0%$1.97M-33.7%
$201.92M+111%$125.2M+17.2%$93.6M+335%$105.97M+300%$95.91M+207%
$7.24M+319%$4.96M+245%$4.07M+151%$3.25M+106%$1.73M+6.3%
$0-100%$4.23M-57.1%$6.7M-31.7%$9.17M-6.1%
$7.05M-64.9%$9M-76.0%$10.93M-28.4%$14.72M+5.1%$20.07M+48.3%
$1.05M+15.8%$1.01M+15.9%$973K+15.8%$939K+15.9%$904K+15.7%
$63.89M+201%$73.27M+80.7%$13.47M-63.4%$15.76M-56.8%$21.23M-15.9%
$733K+48.7%$550K+17.3%$550K+70.8%$549K+81.2%$493K+68.8%
-$239.25M-29.4%-$230.39M-19.9%-$200.89M-12.8%-$189.62M-13.2%-$184.83M-27.2%
$138.03M+84.8%$51.92M-21.7%$80.12M+625%$90.21M+1,005%$74.68M+1,149%
$201.92M+111%$125.2M+17.2%$93.6M+335%$105.97M+300%$95.91M+207%

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

What are Candel Therapeutics, Inc.'s total assets?
Candel Therapeutics, Inc. (CADL) holds $201.9M in total assets, up 110.5% year over year.
How much debt does Candel Therapeutics, Inc. have?
Candel Therapeutics, Inc. carries $2.8M in total debt against $138.0M of shareholders' equity, a debt-to-equity ratio of 0.02.
How much cash does Candel Therapeutics, Inc. have?
Candel Therapeutics, Inc. holds $194.8M in cash and equivalents.
Can Candel Therapeutics, Inc. cover its short-term obligations?
Its current ratio is 28.05 — current assets exceed current liabilities.
Where does Candel Therapeutics, Inc.'s balance sheet data come from?
Every line is extracted from Candel Therapeutics, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.